Enriqueta Felip, MD, PhD, discussed the benefits of subcutaneous pembrolizumab for patients with metastatic non–small cell lung cancer.
Enriqueta Felip, MD, PhD
Advertisement
Articles by Enriqueta Felip, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Breaking News: CVS Buys Rite Aid, Bartell Drugs
3
FDA Approves 1-Minute HIV Self-Test
4
Celebrating the Pharmacist’s Impact: How Pharmacists Elevate Care in Every Setting
5
